Maven Securities LTD Grows Stock Holdings in Bruker Co. (NASDAQ:BRKR)

Maven Securities LTD boosted its stake in shares of Bruker Co. (NASDAQ:BRKR) by 400.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 20,000 shares of the medical research company’s stock after acquiring an additional 16,000 shares during the quarter. Maven Securities LTD’s holdings in Bruker were worth $1,276,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. TD Asset Management Inc lifted its stake in shares of Bruker by 7.4% in the first quarter. TD Asset Management Inc now owns 1,788,763 shares of the medical research company’s stock worth $168,036,000 after buying an additional 123,984 shares in the last quarter. Lighthouse Investment Partners LLC acquired a new stake in Bruker in the fourth quarter valued at approximately $3,366,000. Nomura Holdings Inc. acquired a new stake in shares of Bruker in the 4th quarter valued at $5,593,000. Iron Triangle Partners LP lifted its holdings in Bruker by 4.4% during the 4th quarter. Iron Triangle Partners LP now owns 450,000 shares of the medical research company’s stock worth $33,066,000 after buying an additional 19,157 shares during the last quarter. Finally, Congress Wealth Management LLC DE lifted its stake in Bruker by 21.8% during the first quarter. Congress Wealth Management LLC DE now owns 162,191 shares of the medical research company’s stock worth $15,236,000 after purchasing an additional 29,029 shares during the last quarter. 79.52% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

BRKR has been the subject of a number of research analyst reports. Citigroup decreased their target price on Bruker from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, July 10th. TD Cowen dropped their price target on shares of Bruker from $74.00 to $72.00 and set a “hold” rating on the stock in a research note on Wednesday, August 7th. Wolfe Research downgraded Bruker from an “outperform” rating to a “peer perform” rating in a report on Monday. The Goldman Sachs Group decreased their price target on Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a research note on Tuesday, July 9th. Finally, Wells Fargo & Company began coverage on shares of Bruker in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $78.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $81.40.

Bruker Stock Performance

BRKR stock opened at $66.76 on Wednesday. The company has a 50-day simple moving average of $65.29 and a 200 day simple moving average of $71.48. The company has a market capitalization of $9.70 billion, a P/E ratio of 24.28, a PEG ratio of 2.43 and a beta of 1.18. Bruker Co. has a fifty-two week low of $53.79 and a fifty-two week high of $94.86. The company has a quick ratio of 0.75, a current ratio of 1.65 and a debt-to-equity ratio of 1.18.

Bruker (NASDAQ:BRKR) last released its quarterly earnings data on Tuesday, August 6th. The medical research company reported $0.52 earnings per share for the quarter, hitting the consensus estimate of $0.52. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The business had revenue of $800.70 million during the quarter, compared to analyst estimates of $799.44 million. During the same period last year, the company posted $0.50 EPS. The company’s revenue was up 17.4% compared to the same quarter last year. Sell-side analysts predict that Bruker Co. will post 2.61 earnings per share for the current fiscal year.

Bruker Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Monday, September 2nd were paid a $0.05 dividend. The ex-dividend date of this dividend was Friday, August 30th. This represents a $0.20 dividend on an annualized basis and a yield of 0.30%. Bruker’s dividend payout ratio (DPR) is currently 7.27%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.